TrialNeuropsychopharmacology reports2020

Early improvements of individual symptoms as a predictor of treatment response to asenapine in patients with schizophrenia.

Kamiyu Ogyu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.